Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study (Q44835560)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 April 2004
edit
Language Label Description Also known as
English
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
scientific article published on 8 April 2004

    Statements

    Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study (English)
    8 April 2004
    792-798

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit